Compare uniQure N.V. Ordinary Shares (QURE) vs Sunrun Inc (RUN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
uniQure N.V. Ordinary Shares vs Sunrun Inc — how do they compare? uniQure N.V. Ordinary Shares trades at $20.67 (market cap $1.45B), while Sunrun Inc trades at $7.27 (market cap $1.76B). The key difference: Sunrun Inc is the larger of the two by market cap, and uniQure N.V. Ordinary Shares is trading nearer its 52-week high, Sunrun Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold uniQure N.V. Ordinary Shares for 0 Days and Sunrun Inc for 16 Days on average.
| QURE | RUN | |
|---|---|---|
Market Cap | $1.45B | $1.76B |
Volume | 3,323,243 | 8,936,104 |
Sector | Health | Energy |
52-Week High | $70.59 | $21.41 |
52-Week Low | $9.03 | $7.30 |
Typical Hold Time | 0 Days | 16 Days |
Enterprise Value | $707.46M | $16.28B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Sunrun (RUN) trades at $7.79, up 2.64% today, yet remains in a technical downtrend with bearish moving averages. The company shows strong earnings beats in recent quarters but faces profitability pressure, with net income margin declining from 15.21% in 2025 to 11.59% in 2026. Recent news highlights operational milestones like a record 580 MW grid dispatch with Tesla, but solar sector headwinds from high borrowing costs weigh on sentiment.
Analyst consensus is bullish with a $14.45 price target, yet the stock trades at a discount to peers with a P/E of 4.96. Key risks include negative operating cash flow, high debt levels, and industry-wide financing challenges. The valuation appears attractive, but execution on subscriber growth and margin improvement is critical for upside realization.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About uniQure N.V. Ordinary Shares
uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →About Sunrun Inc
Sunrun Inc. is one of the largest residential solar, battery storage, and energy services companies in the United States. The company provides solar panel installations, battery backup systems, and energy management solutions to homeowners. Sunrun primarily uses a solar-as-a-service model, offering customers solar leases and power purchase agreements (PPAs), which allow homeowners to adopt solar energy with little to no upfront cost. The company's mission is to create a planet run by the sun.
Read more on RUN →
